Evidence map›Paper›PMID 35651103›Full record

ArticleSingapore medical journal2024

Association of systemic vitamin D on the course of dengue virus infection in adults: a single-centre dengue cohort study at a large institution in Singapore.

Sapna P Sadarangani, Htet Lin Htun, Weiping Ling, Robert Hawkins, Tsin Wen Yeo, Laura Rivino, Paul A MacAry, Yee-Sin Leo

Open access · diamondAbstract read
In one paragraph

Article in Singapore medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Sapna P SadaranganiDepartment of Infectious Diseases, Tan Tock Seng Hospital, Singapore.ORCID 0000-0002-8781-0713
Htet Lin HtunDepartment of Preventive and Population Medicine, Office of Clinical Epidemiology, Analytics and Knowledge (OCEAN), Tan Tock Seng Hospital, Singapore.ORCID 0000-0003-2307-0610
Weiping LingDepartment of Infectious Diseases, Tan Tock Seng Hospital, Singapore.ORCID 0000-0001-5803-3831
Robert HawkinsDepartment of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.
Tsin Wen YeoDepartment of Infectious Diseases, Tan Tock Seng Hospital, Singapore.ORCID 0000-0002-4060-7902
Laura RivinoEmerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore.ORCID 0000-0001-6213-9794
Paul A MacAryDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0002-1139-8996
Yee-Sin LeoDepartment of Infectious Diseases, Tan Tock Seng Hospital, Singapore.ORCID 0000-0003-4978-5825
Nanyang Technological University · SGTan Tock Seng Hospital · SGDuke-NUS Medical School · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHost immune responses may impact dengue severity in adults. Vitamin D has multiple immunomodulatory effects on innate and adaptive immunity.

methodsWe evaluated the association between systemic 25-hydroxyvitamin D [25-(OH) D] and dengue disease severity in adults. We measured plasma for total 25-(OH) D levels with an electrochemiluminescence immunoassay using stored samples from participants with laboratory-confirmed dengue, who were prospectively enrolled in 2012-2016 at our institution.

resultsA total of 80 participants (median age 43 years) were enrolled in the study. Six participants had severe dengue based on the World Health Organization (WHO) 1997 criteria (i.e. dengue haemorrhagic fever/dengue shock syndrome) and another six had severe dengue based on the WHO 2009 criteria. Median 25-(OH) D at the acute phase of dengue was 6.175 (interquartile range 3.82-8.21, range 3.00-15.29) mcg/L in all participants. The 25-(OH) D showed an inverse linear trend with severe dengue manifestations based on the WHO 2009 criteria (adjusted risk ratio 0.72, 95% confidence interval 0.57-0.91, P < 0.01) after adjustment for age, gender and ethnicity.

conclusionLimited studies have evaluated the role of systemic 25-(OH) D on dengue severity. Our study found low systemic 25-(OH) D was associated with increased dengue disease severity, particularly for severe bleeding that was not explained by thrombocytopenia. Further studies investigating the underlying immune mechanisms and effects on the vascular endothelium are needed.

Indexed as

DengueVitamin DAdultCohort StudiesDengue VirusFemaleHumansMaleMiddle AgedProspective StudiesSevere DengueSeverity of Illness IndexSingaporeVitamin D Deficiency25-hydroxyvitamin DVitamin D

Identifiers

PMID35651103
PMCPMC11232714
OpenAlexW4281669460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.